Last reviewed · How we verify

Contrast agent

University Hospital Muenster · FDA-approved active Small molecule

Contrast agents enhance the visibility of internal body structures during medical imaging by altering the magnetic properties or radiodensity of tissues.

Contrast agents enhance the visibility of internal body structures during medical imaging by altering the magnetic properties or radiodensity of tissues. Used for Enhancement of medical imaging procedures (MRI, CT, ultrasound, or radiography).

At a glance

Generic nameContrast agent
SponsorUniversity Hospital Muenster
Drug classContrast agent
ModalitySmall molecule
Therapeutic areaDiagnostic Imaging
PhaseFDA-approved

Mechanism of action

Contrast agents work by accumulating in specific tissues or body regions and either absorbing, emitting, or reflecting imaging signals differently than surrounding tissue. This creates enhanced contrast between target structures and background, allowing radiologists to visualize anatomical details, blood flow, organ function, and pathological changes more clearly during imaging procedures such as MRI, CT, ultrasound, or X-ray.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results